GSE86982 | GSM2317742 | Illumina HiSeq 2500 | Homo sapiens | 54Dn1SK_H06_smart-seq | cultured embryonic stem cells[DCX-][RM165051][viral_barcoded] | days in culture: 54; cre line: DCX-; differentiation#: RM165051; control: FALSE; viral barcoded: viral_barcoded |
GSE86982 | GSM2317998 | Illumina HiSeq 2500 | Homo sapiens | 54Dp5_H04_smart-seq | cultured embryonic stem cells[DCX+][RM165048] | days in culture: 54; cre line: DCX+; differentiation#: RM165048; control: FALSE |
GSE86982 | GSM2318254 | Illumina HiSeq 2500 | Homo sapiens | SK_2_F10_smart-seq | cultured embryonic stem cells[RM165095][viral_barcoded] | days in culture: 54; differentiation#: RM165095; control: FALSE; viral barcoded: viral_barcoded |
GSE49321 | GSM1197383 | Illumina HiSeq 2000 | Homo sapiens | BC_12 | DG-75 | cell line: DG-75; library prep protocol: SMART-Seq2 |
GSE52529 | GSM1269057 | Illumina HiSeq 2500 | Homo sapiens | Cell T24_CT_A02 | Human Skeletal Muscle Myoblasts (HSMM) | cell type: Human Skeletal Muscle Myoblasts (HSMM); hour post serum-switch: 24; debris: FALSE; control well: TRUE; cells in well: ~250; library protocol: Single-cell |
GSE52529 | GSM1269313 | Illumina HiSeq 2000 | Homo sapiens | Cell T72_CT_G05 | Human Skeletal Muscle Myoblasts (HSMM) | cell type: Human Skeletal Muscle Myoblasts (HSMM); hour post serum-switch: 72; debris: FALSE; control well: FALSE; cells in well: 0; library protocol: Single-cell |
GSE57872 | GSM1395442 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_MGH26_D08 | glioblastoma [None] | patient id: MGH26; cell type: Glioblastoma; subtype: None |
GSE57872 | GSM1395698 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_MGH29_A12 | glioblastoma [Neu+Mes] | patient id: MGH29; cell type: Glioblastoma; subtype: Neu+Mes |
GSE57872 | GSM1396210 | Illumina HiSeq 2500 | Homo sapiens | Single cell mRNA-seq_CSC8_D08 | gliomasphere CSC8 | cell line: CSC8; cell type: Gliomasphere Cell Line |
GSE64016 | GSM1562538 | Illumina HiSeq 2500 | Homo sapiens | H1_Exp3.229 | single H1 hESC | cell type: human embryonic stem cells; passages: 30-35; treatment: not sorted |